Product Code: TMRGL2385
TMR's report on the global cardiovascular diagnostic & monitoring devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global cardiovascular diagnostic & monitoring devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cardiovascular diagnostic & monitoring devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cardiovascular diagnostic & monitoring devices market.
The report delves into the competitive landscape of the global cardiovascular diagnostic & monitoring devices market. Key players operating in the global cardiovascular diagnostic & monitoring devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cardiovascular diagnostic & monitoring devices market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cardiovascular Diagnostic & Monitoring Devices Market
4. Market Overview
- 4.1. Introduction
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, 2017-2031
- 4.5. Porter's Five Force Analysis
5. Key Insights
- 5.1. Disease Prevalence & Incidence Rate
- 5.2. Key Product/Brand Analysis
- 5.3. Smart wearable devices in cardiovascular care: where we are and how to move forward
- 5.4. Value Chain Analysis
- 5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. ECG Devices
- 6.3.1.1. Resting ECG Devices
- 6.3.1.2. Stress ECG Devices
- 6.3.2. Holter Monitors
- 6.3.3. Event Monitors
- 6.3.4. Implantable Loop Recorders
- 6.3.5. Mobile Cardiac Telemetry
- 6.4. Market Attractiveness Analysis, by Product
7. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by End-user, 2017-2031
- 7.3.1. Hospitals
- 7.3.2. Clinics
- 7.3.3. Ambulatory Surgery Centers
- 7.3.4. Others
- 7.4. Market Attractiveness Analysis, by End-user
8. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by Region
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Region
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness Analysis, by Region
9. North America Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Market Value Forecast, by Product, 2017-2031
- 9.2.1. ECG Devices
- 9.2.1.1. Resting ECG Devices
- 9.2.1.2. Stress ECG Devices
- 9.2.2. Holter Monitors
- 9.2.3. Event Monitors
- 9.2.4. Implantable Loop Recorders
- 9.2.5. Mobile Cardiac Telemetry
- 9.3. Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospitals
- 9.3.2. Clinics
- 9.3.3. Ambulatory Surgery Centers
- 9.3.4. Others
- 9.4. Market Value Forecast, by Country, 2017-2031
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Product
- 9.5.2. By End-user
- 9.5.3. By Country
10. Europe Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Product, 2017-2031
- 10.2.1. ECG Devices
- 10.2.1.1. Resting ECG Devices
- 10.2.1.2. Stress ECG Devices
- 10.2.2. Holter Monitors
- 10.2.3. Event Monitors
- 10.2.4. Implantable Loop Recorders
- 10.2.5. Mobile Cardiac Telemetry
- 10.3. Market Value Forecast, by End-user, 2017-2031
- 10.3.1. Hospitals
- 10.3.2. Clinics
- 10.3.3. Ambulatory Surgery Centers
- 10.3.4. Others
- 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Spain
- 10.4.5. Italy
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Product
- 10.5.2. By End-user
- 10.5.3. By Country/Sub-region
11. Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. ECG Devices
- 11.2.1.1. Resting ECG Devices
- 11.2.1.2. Stress ECG Devices
- 11.2.2. Holter Monitors
- 11.2.3. Event Monitors
- 11.2.4. Implantable Loop Recorders
- 11.2.5. Mobile Cardiac Telemetry
- 11.3. Market Value Forecast, by End-user, 2017-2031
- 11.3.1. Hospitals
- 11.3.2. Clinics
- 11.3.3. Ambulatory Surgery Centers
- 11.3.4. Others
- 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Product
- 11.5.2. By End-user
- 11.5.3. By Country/Sub-region
12. Latin America Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. ECG Devices
- 12.2.1.1. Resting ECG Devices
- 12.2.1.2. Stress ECG Devices
- 12.2.2. Holter Monitors
- 12.2.3. Event Monitors
- 12.2.4. Implantable Loop Recorders
- 12.2.5. Mobile Cardiac Telemetry
- 12.3. Market Value Forecast, by End-user, 2017-2031
- 12.3.1. Hospitals
- 12.3.2. Clinics
- 12.3.3. Ambulatory Surgery Centers
- 12.3.4. Others
- 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Product
- 12.5.2. By End-user
- 12.5.3. By Country/Sub-region
13. Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. ECG Devices
- 13.2.1.1. Resting ECG Devices
- 13.2.1.2. Stress ECG Devices
- 13.2.2. Holter Monitors
- 13.2.3. Event Monitors
- 13.2.4. Implantable Loop Recorders
- 13.2.5. Mobile Cardiac Telemetry
- 13.3. Market Value Forecast, by End-user, 2017-2031
- 13.3.1. Hospitals
- 13.3.2. Clinics
- 13.3.3. Ambulatory Surgery Centers
- 13.3.4. Others
- 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Product
- 13.5.2. By End-user
- 13.5.3. By Country/Sub-region
14. Competition Landscape
- 14.1. Market Player - Competition Matrix (by tier and size of companies)
- 14.2. Market Share Analysis, by Company, 2021
- 14.3. Competitive Business Strategies
- 14.4. Company Profiles
- 14.4.1. Abbott Laboratories
- 14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.4.1.2. Company Financials
- 14.4.1.3. Growth Strategies
- 14.4.1.4. SWOT Analysis
- 14.4.2. Biotronik
- 14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.4.2.2. Company Financials
- 14.4.2.3. Growth Strategies
- 14.4.2.4. SWOT Analysis
- 14.4.3. Boston Scientific Corporation
- 14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.4.3.2. Company Financials
- 14.4.3.3. Growth Strategies
- 14.4.3.4. SWOT Analysis
- 14.4.4. GE Healthcare
- 14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.4.4.2. Company Financials
- 14.4.4.3. Growth Strategies
- 14.4.4.4. SWOT Analysis
- 14.4.5. Medtronic
- 14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.4.5.2. Company Financials
- 14.4.5.3. Growth Strategies
- 14.4.5.4. SWOT Analysis
- 14.4.6. Nihon Kohden Corporation
- 14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.4.6.2. Company Financials
- 14.4.6.3. Growth Strategies
- 14.4.6.4. SWOT Analysis